(Q46953108)

26 December 2017

written work

1 reference

http://drgurunathparale.com/

title

Effects of atorvastatin on higher functions (English)

1 reference

26 December 2017

author

Gurunath Parale

1 reference

http://drgurunathparale.com/

author name string

G P Parale

1

1 reference

26 December 2017

N N Baheti

2

1 reference

26 December 2017

P M Kulkarni

3

1 reference

26 December 2017

N V Panchal

4

1 reference

26 December 2017

language of work or name

English

1 reference

http://drgurunathparale.com/

publication date

18 February 2006

1 reference

26 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

26 December 2017

volume

62

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

259-265

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-005-0073-z

exact match

0 references

cites work

Do low cholesterol levels slow mental processing?

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0073-Z

Factors associated with cognitive impairment among older Italian inpatients. Gruppo Italiano di Farmacovigilanza nell'Anziano (G.I.F.A.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0073-Z

Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0073-Z

Cholesterol and violence: is there a connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0073-Z

The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0073-Z

Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0073-Z

Cholesterol, violent death, and mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0073-Z

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

Simvastatin-associated memory loss

1 reference

12 December 2020

Statins and the risk of dementia

1 reference

12 December 2020

HMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejection.

1 reference

12 December 2020

Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk

1 reference

12 December 2020

Muscle side effects associated with simvastatin therapy

1 reference

12 December 2020

Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering

1 reference

12 December 2020

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

1 reference

12 December 2020

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

12 December 2020

Effects of lovastatin on cognitive function and psychological well-being

1 reference

12 December 2020

Cholesterol metabolism in the brain

1 reference

12 December 2020

Serum lipoprotein levels, statin use, and cognitive function in older women

1 reference

12 December 2020

Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust

1 reference

12 December 2020

Cognitive impairment associated with atorvastatin and simvastatin

1 reference

12 December 2020

1 reference

12 December 2020

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

1 reference

12 December 2020

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

12 December 2020

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

12 December 2020

Can altering serum cholesterol affect neurologic function?

1 reference

12 December 2020

Statin treatment and progression of atherosclerotic plaque burden

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry

1 reference

12 December 2020

HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier.

1 reference

12 December 2020

Statin-associated memory loss: analysis of 60 case reports and review of the literature

1 reference

12 December 2020

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

12 December 2020

Hypertension and neuropsychological performance in men: interactive effects of age.

1 reference

12 December 2020

10.1007/S00228-005-0073-Z

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017